MedTrace Logo

Visual and Tactile Scanning Training in Patients With Neglect After Stroke

NCT02309853 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2014-12-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether 20 Sessions of 30 minutes with a visual and tactile scanning training in the personal, peripersonal and extrapersonal space combined with trunk rotation will be feasible and provide better results compared to 20 Sessions of 30 minutes of a standard visual scanning programme.

Conditions

  • Hemispatial Neglect

Interventions

OTHER

Visual and tactile scanning training

20 Sessions of 30 minutes with a visual and tactile scanning training in the personal, peripersonal and extrapersonal space and trunk rotation. The intervention includes visual or tactile scanning training in three different spaces and will be individually adapted to the needs of the patients. 1. Visual or tactile scanning in the personal space 2. Visual or tactile scanning and trunk rotation in the peripersonal space 3. Visual scanning and trunk rotation in the extrapersonal space

OTHER

Uni-modal visual scanning training

20 sessions of 30 minutes with traditional uni-modal visual scanning training in the peripersonal space.

Sponsors & Collaborators

  • University of Applied Sciences of Western Switzerland

    collaborator OTHER

  • HES-SO Valais-Wallis

    lead OTHER

Principal Investigators

  • Martin Sattelmayer, MSc, MA · HES-SO Valais-Wallis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-09-30
Completion
2015-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02309853 on ClinicalTrials.gov